Literature DB >> 26644543

American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline.

Carolyn D Runowicz1, Corinne R Leach2, N Lynn Henry1, Karen S Henry1, Heather T Mackey1, Rebecca L Cowens-Alvarado1, Rachel S Cannady1, Mandi L Pratt-Chapman1, Stephen B Edge1, Linda A Jacobs1, Arti Hurria1, Lawrence B Marks1, Samuel J LaMonte1, Ellen Warner1, Gary H Lyman1, Patricia A Ganz1.   

Abstract

The purpose of the American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline is to provide recommendations to assist primary care and other clinicians in the care of female adult survivors of breast cancer. A systematic review of the literature was conducted using PubMed through April 2015. A multidisciplinary expert workgroup with expertise in primary care, gynecology, surgical oncology, medical oncology, radiation oncology, and nursing was formed and tasked with drafting the Breast Cancer Survivorship Care Guideline. A total of 1,073 articles met inclusion criteria; and, after full text review, 237 were included as the evidence base. Patients should undergo regular surveillance for breast cancer recurrence, including evaluation with a cancer-related history and physical examination, and should be screened for new primary breast cancer. Data do not support performing routine laboratory tests or imaging tests in asymptomatic patients to evaluate for breast cancer recurrence. Primary care clinicians should counsel patients about the importance of maintaining a healthy lifestyle, monitor for post-treatment symptoms that can adversely affect quality of life, and monitor for adherence to endocrine therapy. Recommendations provided in this guideline are based on current evidence in the literature and expert consensus opinion. Most of the evidence is not sufficient to warrant a strong evidence-based recommendation. Recommendations on surveillance for breast cancer recurrence, screening for second primary cancers, assessment and management of physical and psychosocial long-term and late effects of breast cancer and its treatment, health promotion, and care coordination/practice implications are made.This guideline was developed through a collaboration between the American Cancer Society and the American Society of Clinical Oncology and has been published jointly by invitation and consent in both CA: A Cancer Journal for Clinicians and Journal of Clinical Oncology. All rights reserved. No part of this document may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without written permission by the American Cancer Society or the American Society of Clinical Oncology.
© 2015 by American Cancer Society and American Society of Clinical Oncology.

Entities:  

Mesh:

Year:  2015        PMID: 26644543     DOI: 10.1200/JCO.2015.64.3809

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  248 in total

1.  Prospective evaluation of sexual health in breast cancer women during the first year of adjuvant hormonal treatment using a cancer patient's dedicated questionnaire: A glaring gap of communication between health professionals and patients.

Authors:  Leticia Aptecar; Frederic Fiteni; Marta Jarlier; Stephanie Delaine; Violaine Guillerme; William Jacot; Veronique D'Hondt
Journal:  Breast Cancer Res Treat       Date:  2021-01-15       Impact factor: 4.872

2.  Impact of transcranial direct current stimulation on sustained attention in breast cancer survivors: Evidence for feasibility, tolerability, and initial efficacy.

Authors:  Alexandra M Gaynor; Denise Pergolizzi; Yesne Alici; Elizabeth Ryan; Katrazyna McNeal; Tim A Ahles; James C Root
Journal:  Brain Stimul       Date:  2020-04-27       Impact factor: 8.955

Review 3.  Exercise for improving bone health in women treated for stages I-III breast cancer: a systematic review and meta-analyses.

Authors:  Canan P Fornusek; Sharon L Kilbreath
Journal:  J Cancer Surviv       Date:  2017-06-21       Impact factor: 4.442

4.  Estrogen-alone therapy and invasive breast cancer incidence by dose, formulation, and route of delivery: findings from the WHI observational study.

Authors:  Chrisandra Shufelt; C Noel Bairey Merz; Mary B Pettinger; Lydia Choi; Rowan Chlebowski; Carolyn J Crandall; Simin Liu; Dorothy Lane; Ross Prentice; JoAnn E Manson
Journal:  Menopause       Date:  2018-09       Impact factor: 2.953

5.  Follow-up Care for Breast Cancer Survivors.

Authors:  Kathryn J Ruddy; Jeph Herrin; Lindsey Sangaralingham; Rachel A Freedman; Ahmedin Jemal; Tufia C Haddad; Summer V Allen; Tina Hieken; Judy C Boughey; Patricia A Ganz; Rachel D Havyer; Nilay D Shah
Journal:  J Natl Cancer Inst       Date:  2020-01-01       Impact factor: 13.506

6.  Agenda for Translating Physical Activity, Nutrition, and Weight Management Interventions for Cancer Survivors into Clinical and Community Practice.

Authors:  Karen Basen-Engquist; Catherine M Alfano; Melissa Maitin-Shepard; Cynthia A Thomson; Kathryn H Schmitz; Bernardine M Pinto; Kevin Stein; David S Zucker; Karen L Syrjala; Elizabeth Fallon; Colleen Doyle; Wendy Demark-Wahnefried
Journal:  Obesity (Silver Spring)       Date:  2017-11       Impact factor: 5.002

Review 7.  Provision of integrated psychosocial services for cancer survivors post-treatment.

Authors:  Christopher J Recklitis; Karen L Syrjala
Journal:  Lancet Oncol       Date:  2017-01       Impact factor: 41.316

Review 8.  Clinical practice guidelines on the evidence-based use of integrative therapies during and after breast cancer treatment.

Authors:  Heather Greenlee; Melissa J DuPont-Reyes; Lynda G Balneaves; Linda E Carlson; Misha R Cohen; Gary Deng; Jillian A Johnson; Matthew Mumber; Dugald Seely; Suzanna M Zick; Lindsay M Boyce; Debu Tripathy
Journal:  CA Cancer J Clin       Date:  2017-04-24       Impact factor: 508.702

Review 9.  Adjuvant Endocrine Therapy in Breast Cancer: Evolving Paradigms in Premenopausal Women.

Authors:  Lorenzo Rossi; Olivia Pagani
Journal:  Curr Treat Options Oncol       Date:  2017-05

10.  The association of pharmacy fill synchronization with breast cancer endocrine therapy adherence.

Authors:  Joan M Neuner; Nicole M Fergestrom; Purushottam W Laud; Ann B Nattinger; Kirsten M M Beyer; Kathryn E Flynn; Liliana E Pezzin
Journal:  Cancer       Date:  2019-08-02       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.